-5%
Deflazacort works by inhibiting the enzyme Phospholipase A2, reducing prostaglandin synthesis, and suppressing the immune system by lowering the release of certain immune-related chemicals.
Deflazit is prescribed for the treatment of various conditions, including:
- Severe allergic reactions such as anaphylaxis, asthma, and hypersensitivity reactions
- Autoimmune and inflammatory diseases like rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica, systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (excluding systemic sclerosis), polyarteritis nodosa, and sarcoidosis
- Skin disorders such as pemphigus, bullous pemphigoid, and pyoderma gangrenosum
- Kidney conditions like minimal change nephrotic syndrome and acute interstitial nephritis
- Heart issues such as rheumatic carditis
- Inflammatory bowel diseases including ulcerative colitis and Crohn’s disease
- Eye conditions like uveitis and optic neuritis
- Blood disorders including autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura
- Cancers such as acute and lymphatic leukemia, malignant lymphoma, and multiple myeloma
- Immune Suppression in organ transplantation